{"entity":{"type":"insider","cik":"0001645470","url":"/insider/0001645470","json_url":"/insider/0001645470.json","name":"Collier Alan Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":780,"n_filings":62,"first":"2019-01-14","last":"2020-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Collier Alan Brian","source":"filing","n_filings":62,"first_seen":"2019-01-14","last_seen":"2020-07-07"}],"transactions":[{"id":2548755,"accession":"0001645470-20-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645470-20-000005","line_url":"/filing/0001645470-20-000005#line-3","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.1024,"price_display":"0.10","price_state":"stated","total_value":10.24,"total_display":"10.24","shares_owned_after":26219.0,"shares_owned_after_display":"26,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-07","scope":"insider"},{"id":2548744,"accession":"0001645470-20-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-20-000005","line_url":"/filing/0001645470-20-000005#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.1004,"price_display":"0.10","price_state":"stated","total_value":10.04,"total_display":"10.04","shares_owned_after":26119.0,"shares_owned_after_display":"26,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-07","scope":"insider"},{"id":2548734,"accession":"0001645470-20-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-20-000005","line_url":"/filing/0001645470-20-000005#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.1035,"price_display":"0.10","price_state":"stated","total_value":20.7,"total_display":"20.70","shares_owned_after":26019.0,"shares_owned_after_display":"26,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-07","scope":"insider"},{"id":2654088,"accession":"0001645470-20-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-20-000004","line_url":"/filing/0001645470-20-000004#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.9649,"price_display":"0.96","price_state":"stated","total_value":96.49,"total_display":"96.49","shares_owned_after":25819.0,"shares_owned_after_display":"25,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-22","filed_date":"2020-02-26","scope":"insider"},{"id":9294094,"accession":"0001645470-20-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-20-000003","line_url":"/filing/0001645470-20-000003#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":175.0,"total_display":"175.00","shares_owned_after":25719.0,"shares_owned_after_display":"25,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-24","scope":"insider"},{"id":3152400,"accession":"0001645470-20-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-20-000001","line_url":"/filing/0001645470-20-000001#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":175.0,"total_display":"175.00","shares_owned_after":25418897.0,"shares_owned_after_display":"25,418,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-23","scope":"insider"},{"id":9294093,"accession":"0001645470-20-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-20-000003","line_url":"/filing/0001645470-20-000003#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":225.0,"total_display":"225.00","shares_owned_after":25619.0,"shares_owned_after_display":"25,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-30","filed_date":"2020-01-24","scope":"insider"},{"id":3152396,"accession":"0001645470-20-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-20-000001","line_url":"/filing/0001645470-20-000001#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":225.0,"total_display":"225.00","shares_owned_after":25418797.0,"shares_owned_after_display":"25,418,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-30","filed_date":"2020-01-23","scope":"insider"},{"id":9294087,"accession":"0001645470-20-000002","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-7","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":150.0,"total_display":"150.00","shares_owned_after":25519.0,"shares_owned_after_display":"25,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2020-01-24","scope":"insider"},{"id":8561186,"accession":"0001645470-19-000057","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-7","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.0015,"price_display":"0.00","price_state":"stated","total_value":0.15,"total_display":"0.15","shares_owned_after":25418697.0,"shares_owned_after_display":"25,418,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-31","scope":"insider"},{"id":9294088,"accession":"0001645470-20-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-6","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.0015,"price_display":"0.00","price_state":"stated","total_value":0.75,"total_display":"0.75","shares_owned_after":25418597.0,"shares_owned_after_display":"25,418,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2020-01-24","scope":"insider"},{"id":8561182,"accession":"0001645470-19-000057","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-6","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.0015,"price_display":"0.00","price_state":"stated","total_value":0.75,"total_display":"0.75","shares_owned_after":25418597.0,"shares_owned_after_display":"25,418,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-31","scope":"insider"},{"id":9294089,"accession":"0001645470-20-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-5","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0022,"price_display":"0.00","price_state":"stated","total_value":2.2,"total_display":"2.20","shares_owned_after":25418097.0,"shares_owned_after_display":"25,418,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2020-01-24","scope":"insider"},{"id":8561178,"accession":"0001645470-19-000057","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-5","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0022,"price_display":"0.00","price_state":"stated","total_value":2.2,"total_display":"2.20","shares_owned_after":25418097.0,"shares_owned_after_display":"25,418,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-31","scope":"insider"},{"id":9294091,"accession":"0001645470-20-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-3","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.002,"price_display":"0.00","price_state":"stated","total_value":2.0,"total_display":"2.00","shares_owned_after":25416997.0,"shares_owned_after_display":"25,416,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2020-01-24","scope":"insider"},{"id":9294090,"accession":"0001645470-20-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-4","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.0019,"price_display":"0.00","price_state":"stated","total_value":0.19,"total_display":"0.19","shares_owned_after":25417097.0,"shares_owned_after_display":"25,417,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2020-01-24","scope":"insider"},{"id":8561175,"accession":"0001645470-19-000057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-4","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.002,"price_display":"0.00","price_state":"stated","total_value":2.0,"total_display":"2.00","shares_owned_after":25416997.0,"shares_owned_after_display":"25,416,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-31","scope":"insider"},{"id":8561172,"accession":"0001645470-19-000057","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-3","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":0.0019,"price_display":"0.00","price_state":"stated","total_value":0.19,"total_display":"0.19","shares_owned_after":25417097.0,"shares_owned_after_display":"25,417,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-31","scope":"insider"},{"id":9294092,"accession":"0001645470-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0028,"price_display":"0.00","price_state":"stated","total_value":5.6,"total_display":"5.60","shares_owned_after":25414997.0,"shares_owned_after_display":"25,414,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2020-01-24","scope":"insider"},{"id":9294086,"accession":"0001645470-20-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-20-000002","line_url":"/filing/0001645470-20-000002#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0025,"price_display":"0.00","price_state":"stated","total_value":2.5,"total_display":"2.50","shares_owned_after":25415997.0,"shares_owned_after_display":"25,415,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2020-01-24","scope":"insider"},{"id":8561169,"accession":"0001645470-19-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0028,"price_display":"0.00","price_state":"stated","total_value":5.6,"total_display":"5.60","shares_owned_after":25414997.0,"shares_owned_after_display":"25,414,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-31","scope":"insider"},{"id":8561164,"accession":"0001645470-19-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-19-000057","line_url":"/filing/0001645470-19-000057#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0025,"price_display":"0.00","price_state":"stated","total_value":2.5,"total_display":"2.50","shares_owned_after":25415997.0,"shares_owned_after_display":"25,415,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-31","scope":"insider"},{"id":8201605,"accession":"0001645470-19-000056","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-8","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0028,"price_display":"0.00","price_state":"stated","total_value":5.6,"total_display":"5.60","shares_owned_after":25412997.0,"shares_owned_after_display":"25,412,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-09","scope":"insider"},{"id":8201600,"accession":"0001645470-19-000056","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-7","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0029,"price_display":"0.00","price_state":"stated","total_value":5.8,"total_display":"5.80","shares_owned_after":25410997.0,"shares_owned_after_display":"25,410,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-09","scope":"insider"},{"id":8201597,"accession":"0001645470-19-000056","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-6","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0029,"price_display":"0.00","price_state":"stated","total_value":5.8,"total_display":"5.80","shares_owned_after":25408997.0,"shares_owned_after_display":"25,408,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-09","scope":"insider"},{"id":8201593,"accession":"0001645470-19-000056","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-5","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0029,"price_display":"0.00","price_state":"stated","total_value":5.8,"total_display":"5.80","shares_owned_after":25406997.0,"shares_owned_after_display":"25,406,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-09","scope":"insider"},{"id":8201590,"accession":"0001645470-19-000056","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-4","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0029,"price_display":"0.00","price_state":"stated","total_value":5.8,"total_display":"5.80","shares_owned_after":25404997.0,"shares_owned_after_display":"25,404,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-29","filed_date":"2019-12-09","scope":"insider"},{"id":8201586,"accession":"0001645470-19-000056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-3","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0035,"price_display":"0.00","price_state":"stated","total_value":7.0,"total_display":"7.00","shares_owned_after":25402997.0,"shares_owned_after_display":"25,402,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-12-09","scope":"insider"},{"id":8201583,"accession":"0001645470-19-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0035,"price_display":"0.00","price_state":"stated","total_value":3.5,"total_display":"3.50","shares_owned_after":25400997.0,"shares_owned_after_display":"25,400,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-12-09","scope":"insider"},{"id":8201579,"accession":"0001645470-19-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-19-000056","line_url":"/filing/0001645470-19-000056#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0035,"price_display":"0.00","price_state":"stated","total_value":7.0,"total_display":"7.00","shares_owned_after":25399997.0,"shares_owned_after_display":"25,399,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-12-09","scope":"insider"},{"id":8489261,"accession":"0001645470-19-000055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645470-19-000055","line_url":"/filing/0001645470-19-000055#line-3","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0038,"price_display":"0.00","price_state":"stated","total_value":3.8,"total_display":"3.80","shares_owned_after":25397997.0,"shares_owned_after_display":"25,397,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-26","scope":"insider"},{"id":8489256,"accession":"0001645470-19-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-19-000055","line_url":"/filing/0001645470-19-000055#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0038,"price_display":"0.00","price_state":"stated","total_value":3.8,"total_display":"3.80","shares_owned_after":25396997.0,"shares_owned_after_display":"25,396,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-26","scope":"insider"},{"id":8489253,"accession":"0001645470-19-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-19-000055","line_url":"/filing/0001645470-19-000055#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.0037,"price_display":"0.00","price_state":"stated","total_value":3.7,"total_display":"3.70","shares_owned_after":25395997.0,"shares_owned_after_display":"25,395,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-26","scope":"insider"},{"id":8657500,"accession":"0001645470-19-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-19-000054","line_url":"/filing/0001645470-19-000054#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (Ceo)","officer_title":"Ceo","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0071,"price_display":"0.01","price_state":"stated","total_value":14.2,"total_display":"14.20","shares_owned_after":25394997.0,"shares_owned_after_display":"25,394,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-15","scope":"insider"},{"id":7850736,"accession":"0001645470-19-000053","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-12","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.0058,"price_display":"0.01","price_state":"stated","total_value":58.0,"total_display":"58.00","shares_owned_after":25392997.0,"shares_owned_after_display":"25,392,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-04","scope":"insider"},{"id":7850733,"accession":"0001645470-19-000053","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-11","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.006,"price_display":"0.01","price_state":"stated","total_value":30.0,"total_display":"30.00","shares_owned_after":25382997.0,"shares_owned_after_display":"25,382,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-04","scope":"insider"},{"id":7850729,"accession":"0001645470-19-000053","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-10","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.006,"price_display":"0.01","price_state":"stated","total_value":30.0,"total_display":"30.00","shares_owned_after":25377997.0,"shares_owned_after_display":"25,377,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850727,"accession":"0001645470-19-000053","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-9","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.0049,"price_display":"0.00","price_state":"stated","total_value":24.5,"total_display":"24.50","shares_owned_after":25372997.0,"shares_owned_after_display":"25,372,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850724,"accession":"0001645470-19-000053","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-8","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.0049,"price_display":"0.00","price_state":"stated","total_value":24.5,"total_display":"24.50","shares_owned_after":25367997.0,"shares_owned_after_display":"25,367,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850722,"accession":"0001645470-19-000053","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-7","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.0048,"price_display":"0.00","price_state":"stated","total_value":24.0,"total_display":"24.00","shares_owned_after":25357997.0,"shares_owned_after_display":"25,357,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850719,"accession":"0001645470-19-000053","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-6","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.0047,"price_display":"0.00","price_state":"stated","total_value":23.5,"total_display":"23.50","shares_owned_after":25347997.0,"shares_owned_after_display":"25,347,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850716,"accession":"0001645470-19-000053","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-5","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.0045,"price_display":"0.00","price_state":"stated","total_value":22.5,"total_display":"22.50","shares_owned_after":25352997.0,"shares_owned_after_display":"25,352,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850715,"accession":"0001645470-19-000053","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-4","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.0043,"price_display":"0.00","price_state":"stated","total_value":21.5,"total_display":"21.50","shares_owned_after":25362997.0,"shares_owned_after_display":"25,362,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"},{"id":7850712,"accession":"0001645470-19-000053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-3","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.0092,"price_display":"0.01","price_state":"stated","total_value":4.6,"total_display":"4.60","shares_owned_after":25342997.0,"shares_owned_after_display":"25,342,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-11-04","scope":"insider"},{"id":7850709,"accession":"0001645470-19-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-2","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.0089,"price_display":"0.01","price_state":"stated","total_value":4.45,"total_display":"4.45","shares_owned_after":25342497.0,"shares_owned_after_display":"25,342,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-11-04","scope":"insider"},{"id":7850707,"accession":"0001645470-19-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645470-19-000053","line_url":"/filing/0001645470-19-000053#line-1","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.0095,"price_display":"0.01","price_state":"stated","total_value":1.9,"total_display":"1.90","shares_owned_after":25341997.0,"shares_owned_after_display":"25,341,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-17","filed_date":"2019-11-04","scope":"insider"},{"id":8561161,"accession":"0001645470-19-000052","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001645470-19-000052","line_url":"/filing/0001645470-19-000052#line-8","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0105,"price_display":"0.01","price_state":"stated","total_value":21.0,"total_display":"21.00","shares_owned_after":25341597.0,"shares_owned_after_display":"25,341,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-15","scope":"insider"},{"id":8561155,"accession":"0001645470-19-000052","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001645470-19-000052","line_url":"/filing/0001645470-19-000052#line-7","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.0108,"price_display":"0.01","price_state":"stated","total_value":2.16,"total_display":"2.16","shares_owned_after":25341797.0,"shares_owned_after_display":"25,341,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-15","scope":"insider"},{"id":8561147,"accession":"0001645470-19-000052","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001645470-19-000052","line_url":"/filing/0001645470-19-000052#line-6","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":2.0,"total_display":"2.00","shares_owned_after":25339797.0,"shares_owned_after_display":"25,339,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-07","filed_date":"2019-10-15","scope":"insider"},{"id":8561143,"accession":"0001645470-19-000052","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001645470-19-000052","line_url":"/filing/0001645470-19-000052#line-5","is_derivative":false,"issuer_cik":"0001528172","issuer_name":"ENDONOVO THERAPEUTICS, INC.","issuer_ticker":"ENDV","issuer_name_source":null,"issuer_url":"/issuer/0001528172","owner_cik":"0001645470","owner_name":"Collier Alan Brian","owner_url":"/insider/0001645470","role":"Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0105,"price_display":"0.01","price_state":"stated","total_value":21.0,"total_display":"21.00","shares_owned_after":25339597.0,"shares_owned_after_display":"25,339,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-04","filed_date":"2019-10-15","scope":"insider"}],"next_cursor":"2019-10-04|8561143","ledger_fault":false,"count":{"value":780,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":780,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":780},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001528172","name":"ENDONOVO THERAPEUTICS, INC.","url":"/issuer/0001528172","role":"Director, Officer (CEO)","n_filings":62,"first_seen":"2019-01-14","last_seen":"2020-07-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001645470","retrieved_at":"2026-08-22T00:15:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}